The healthcare landscape is experiencing a change with the emergence of GLP-1 transdermal systems . These exciting formulations offer a potential approach to administering glucagon-like peptide-1 medication for individuals managing type 2 diabetes . Instead of daily shots , a simple patch affixed to the skin could provide a steady dose of the subst